Emulate, Inc., a leading provider of next-generation in vitro models, today welcomed the U.S. Food and Drug Administration's (FDA) newly announced plan to reduce reliance on animal testing in ...
The last few weeks have been busy for Jim Corbett. Corbett, the CEO of organ-chip developer Emulate, has been fielding requests from potential clients, as well as from early investors who say they ...
Can organ-on-a-chip technology solve drug development’s biggest challenge—poor clinical success rates? Dr. Lorna Ewart ...
Harvard's Wyss Institute and Emulate Bio say results from the AVATAR project could provide insights on how travel into deep ...
RISC-V architecture has made a lot of progress in recent years, but when I write about new RISC-V hardware I often add a note that the platform tends to lag behind x86_64 and ARM when it comes to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results